Neuronetics, Inc. (STIM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.5350 |
| Open | 3.4900 |
| Bid | 3.3600 x 500 |
| Ask | 3.4400 x 100 |
| Day's range | 3.2500 - 3.5362 |
| 52-week range | 1.0300 - 5.0700 |
| Volume | |
| Avg. volume | 164,781 |
| Market cap | 101.014M |
| Beta (5Y monthly) | 2.44 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression
Neuronetics (STIM) announces the FDA's approval of NeuroStar Advanced Therapy, which is likely to aid in the treatment of depression in adolescents by acting as a supplement.
- Zacks
Neuronetics (STIM) Progresses in MRD and TRD With New Deal
The collaboration between Neuronetics (STIM) and TCN holds particular significance in the realm of treatment-resistant depression.
- GuruFocus.com
Neuronetics Inc (STIM) Reports Record Revenues in Q4 and Full Year 2023
Strong Utilization Trends and Operational Highlights Drive Growth
© 2024 Yahoo. All rights reserved.